NASDAQ NMS - GLOBAL MARKET · FBLG
-0.88% · -$0.0100 · Vol 71.9K
Market closed · last close 4:00 PM ET · price as of 16:21:31 ET
Fibrobiologics Inc

Fibrobiologics Inc

Biotechnology
$1.13
Card
Relationship Map

Follow $FBLG

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $FBLG by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
FBLG
Fibrobiologics Inc
Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

81/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is FBLG moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading FBLG catalysts
About Fibrobiologics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2024
Employees
15
Country
US

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.12
Day high
$1.14
Day low
$1.05
Previous close
$1.14
52W high
$9.75
-88.41% from high
52W low
$0.6271
6% of range
Market cap
$7.9M
EPS
$-5.7426
Beta
0.48
Shares out
7M
Volume
71.9K
0.31× rel vol
Avg volume
229.7K
VWAP
$1.10
Price history computed in-house
1W
-8.87%
1M
-35.80%
3M
+23.27%
1Y
-88.41%
YTD
-74.88%
SMA 50 $1.31 · below
SMA 200 $2.75 · below
52W position 6%

FBLG overview

Veridion Score
81
Registered · 2026-10-08
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around FBLG.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading FBLG Form 4 filings
Public disclosures

Congress activity in FBLG

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

FBLG contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FBLG in this window.
Lobbying spend

FBLG lobbying filings, year to date.

Registered lobbying filings matched to Fibrobiologics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for FBLG in this window.
Loading news for FBLG
Analyst ratings
Sovereign unlock shows live analyst consensus for FBLG.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.